Gasdermin D, involved in programmed necrosis, promotes the secretion of pro-inflammatory cytokines IL-1β and CCL2 and activates the NF-κB pathway, driving NASH progression (44). Here, CCL2 is linked to metabolic dysfunction-associated steatohepatitis.